Cardiothoracic & vascular anesthesia

Minimum protamine dose required to neutralize heparin in cardiac surgery: a single-centre, prospective, observational cohort study

Can J AnaesthPublished Prospective observational cohort study

Authors' conclusion

The protamine:heparin ratio required to neutralize residual unfractionated heparin (UFH) following CPB is variable. A protamine:heparin ratio of 0.3 was sufficient to neutralize UFH in some patients, while a ratio of 0.5 is sufficient to neutralize both residual anti-IIa and -Xa activity in most patients.

Study context

Population
Consecutive patients undergoing elective cardiac surgery with cardiopulmonary bypass (CPB)25 analysed
Participants
28 patients
Exposure
Cumulative protamine doses of 150, 200, 250 and 300 mg after CPB
Outcome
Least protamine dose necessary to neutralize residual heparin after CPB (anti-IIa and anti-Xa activity)
Methodological detailssingle-centre, consecutive patients, Protamine given by infusion pump at 25 mg·min-1; samples before and after 150, 200, 250 and 300 mg
  • Single-centre
  • Consecutive patients
  • Protamine given by infusion pump at 25 mg·min-1; samples before and after 150, 200, 250 and 300 mg

Main finding

As reported in the abstract

Heparin neutralization (anti-IIa and -Xa activity)

Complete neutralization at first sampling point (150 mg protamine; protamine:heparin ratio 0.3 [0.1])

8 out of 25

32%

Protamine:heparin ratio sufficient for neutralization in > 90% of patients

0.5

0.2

Observational data: associations, not effects.

Secondary outcomes

Post-CPB activated clotting time as surrogate for heparin neutralization

Low to mid-range activated clotting time correlated well with anti-IIa and -Xa activity

Original publication

Minimum protamine dose required to neutralize heparin in cardiac surgery: a single-centre, prospective, observational cohort study. Can J Anaesth. Published 5 December 2022. doi:10.1007/s12630-022-02364-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.